News

Transforming Pharmacy Operations: HDS Launches Script Scan Tool

Transforming Pharmacy Operations: HDS Launches Script Scan Tool

HDS Introduces Script Scan to Boost Pharmacy Efficiency

HDS has launched Script Scan, a new analytics platform built to help pharmacies run smarter and healthier businesses. It brings clear visibility to script-level performance so teams can see what’s working, what isn’t, and where margin is getting lost. The timing matters: pharmacies are managing tighter competition and financial pressure, and every script needs to pull its weight.

Why Script Scan Matters for Pharmacies

Script Scan plugs directly into HDS’s Spotlight platform and is tailored to the realities pharmacies face today. With margins compressed and staffing stretched thin, leaders need quick access to the right numbers. Script Scan delivers that with a straightforward dashboard and reporting suite designed to surface essential data whenever it’s needed, without extra lift from busy teams.

Turn Data Into Decisions

The platform’s data visualization tools make complex performance questions easier to answer. Pharmacies can customize key performance indicators (KPIs), switch between departmental views, and explore trends that inform day-to-day actions and longer-term planning. Dynamic filters let operators zero in on the measures that matter most to their business, whether that’s a specific payer mix, drug category, or internal process step.

Boost Margins with Algorithm-Driven Insights

Script Scan applies more than 40 rules-based algorithms to examine acquisition costs and fee schedules, then highlights where script-level margins can improve. When a claim is processed sub-optimally, the system flags it and routes it into a clear, trackable workflow. That way, teams can focus on resolving the right issues quickly and consistently, instead of hunting for them after the fact.

Staying Connected with the Pharmacy Community

Alongside the release of Script Scan, HDS is deepening its engagement with the pharmacy market. The company has joined the National Association of Specialty Pharmacy (NASP) as a corporate member, underscoring its commitment to collaboration and high standards in pharmacy services. Gary Conte, HDS’s VP of Business Development, now serves on the NASP Technology Committee, helping build ties with stakeholders across the specialty pharmacy ecosystem.

Perspectives on Script Scan’s Impact

NASP President and CEO Sheila Arquette has emphasized the value of working with organizations focused on improving pharmacy outcomes. HDS’s participation signals to the community that a stronger, more coordinated approach to operational results is within reach.

Drawing on his deep experience in specialty pharmacy, Gary Conte echoed that view. He noted that HDS’s innovations are engineered to support pharmacies as they navigate a challenging environment—keeping the focus on practical tools that make a measurable difference.

Getting Started with Script Scan

Script Scan is available as a Software as a Service (SaaS) offering, so pharmacies across the United States can adopt it without major infrastructure changes. It’s flexible enough to fit different pharmacy models and straightforward enough to support teams regardless of size or service mix.

If you’d like to see how Script Scan works in practice, you can find an overview on the HDS website. HDS also invites interested pharmacies to connect for an introductory call and product demonstration for a closer look and a direct line to the team.

About HealthPlan Data Solutions (HDS)

HealthPlan Data Solutions (HDS) is a pharmacy analytics company focused on payment integrity, campaign management, and pharmacy claims insights. Founded by pharmacists and IT experts, HDS develops technology that helps improve pharmacy benefit plans with clear, actionable intelligence. Its Spotlight platform combines more than 500 proprietary scanning algorithms with clinical expertise to turn data into operational insight that pharmacy teams can act on.

Frequently Asked Questions

What is Script Scan?

Script Scan is an analytics platform from HDS that helps pharmacies monitor performance and improve profitability at the script level. It integrates with the Spotlight platform and brings together dashboards, visualizations, and workflow tools in one place.

How does Script Scan improve pharmacy operations?

It provides an at-a-glance dashboard, advanced data visualization, and customizable KPIs and departmental views. With more than 40 rules-based algorithms that analyze acquisition costs and fee schedules, Script Scan flags sub-optimally processed claims and organizes them into a clear workflow, so teams can resolve issues faster and protect margins.

Who can benefit from Script Scan?

Specialty and retail pharmacies across the United States can use Script Scan. It’s especially useful for operators facing margin compression and staffing constraints, and it adapts to different pharmacy sizes, models, and service scopes.

What is HDS’s role in the pharmacy industry?

HDS specializes in pharmacy analytics, delivering solutions for payment integrity, campaign management, and pharmacy claims insights. Its Spotlight platform uses over 500 proprietary scanning algorithms, paired with clinical expertise, to generate actionable insights. HDS also engages with the community through NASP membership and participation on the NASP Technology Committee.

How can I learn more about Script Scan?

You can review an overview on the HDS website and reach out to schedule an introductory call and product demonstration. The HDS team will walk you through the platform and answer questions about fit and adoption.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

eGlint's Rapid Tech Revolutionizes Proteomics with Win

Updated Category News Views 5

A Game-Changer in Proteomics Now ain't this something—eGlint just scooped up the 2026 BioTools Innovator Grand Prize, waving a big ol' $250,000 check around and claiming the biotech spotlight with their swift-moving ProteoNex™ platform. Forget about sticking samples through sluggish labs and waiting an eternity; eGlint's tech is flipping the switch, serving up protein...

Continue Reading
Richard Huffman Joins IFA Board, Strengthens Franchise Ties

Updated Category News Views 17

Ever wonder how the cogs in this massive machine called franchising keep turning? It's folks like Richard Huffman who step up to the plate, and his recent election to the International Franchise Association (IFA) Board of Directors is worth a second glance. Huffman: A Franchise Veteran Now, Huffman isn't some rookie in the world of franchising. You see, back in '94, he...

Continue Reading
Plata Hits $1 Billion ARR in Record Digital Bank Growth

Updated Category News Views 10

Plata Rocks the Boat with Rapid Revenue Growth When a digital bank like Plata rakes in $1 billion in Annual Recurring Revenue (ARR) within just 3.5 years, you can't just shrug it off. That's blazing fast by any standard, especially for a financial institution. Emerging from Mexico, this bank's rocket-like ascent is flinging the doors wide open for what's possible in the...

Continue Reading
Ruth E. Carter Returns Home with Celebrated Exhibition

Updated Category News Views 7

Ruth E. Carter’s Triumphant Return When a titan of the costume design world circles back to their roots, you know it’s bound to be something special. Ruth E. Carter, who has swapped needles and threads for Oscars (twice, mind you), is making a return to Hampton University, paying homage to the very soil that sowed her artistic seeds. Ain't that a capstone of a career...

Continue Reading
Navigating the Nitty-Gritty of Cabin Rental Management

Updated Category News Views 5

The Real Elbow Grease Behind Cabin Management Ever imagined what it’d take to keep a vacation rental cabin running like a tight ship? Well, Nathan Fitts breaks it down real clear-like. The guy's seen it all in Blue Ridge, Georgia, which isn't just about scenic views—there's serious business brewing behind that cabin charm. More Than Just Fluffing Pillows Turns out,...

Continue Reading
2GenPen & LordCap Team Up: Game-Changer in ABS?

Updated Category News Views 8

New Kids on the Structured Credit Block? Well, it looks like we're in for a ride with 2GenPen teaming up with Lord Capital to shake up the asset-backed securities (ABS) world. They're strutting their stuff by launching a strategic collaboration to boost credit analysis. Think of it as a power-up for ABS transactions—because nobody loves a murky credit rating. The Heart...

Continue Reading
LBT Unveils Game-Changing Cyclotron for Medical Advances

Updated Category News Views 8

Unveiling the LB-30 Cyclotron at EANM 2026 Life in nuclear medicine never stands still, and once again, Longevous Beamtech (LBT) is stirring the pot with its brand-new LB-30 series medical cyclotron. They rolled out this high-powered beast at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM 2026) in Vienna. Leaning into the 30 MeV energy...

Continue Reading
CMS Proposal Sparks Controversy in Lab Certification

Updated Category News Views 5

A New Contender in the Battle Over Lab Standards Here's what’s heating up in the realm of clinical laboratories: A proposed shift by the Centers for Medicare & Medicaid Services (CMS) that reeks of cutting corners, if you ask the folks at the Association for Diagnostics & Laboratory Medicine (ADLM). They’re banging the drums against CMS's idea to nix the board...

Continue Reading
Noé Hinojosa Jr. Honored for Leadership in Business

Updated Category News Views 6

From Bonds to Ballgames: Hinojosa's Impact Listen up, because this one’s more than just another accolade on a shelf. Noé Hinojosa Jr., a big gun over at TRB Securities, is getting the 2026 Hispanic Business Salute Award, and it's a doozy. Awarded by all the big wigs—UPS, NBC 5, Telemundo 39, and the Dallas Cowboys—this isn't a small pat on the back. It's a full-on...

Continue Reading
Clean Power Alliance's Bond Deal Secures $91M Savings

Updated Category News Views 9

CPA Triumphs Yet Again With Bond Savings I'll tell you, the Clean Power Alliance (CPA) just hit the jackpot again. We're talking a $1.4 billion energy prepayment bond deal that locks in a whopping $91.1 million in savings over the next seven years. Not bad, huh? A Closer Look at the Numbers CPA's charm—besides being the top green power supplier in the U.S.—is spinning...

Continue Reading

Top 5 Most Recently Viewed Articles

Freeport-McMoRan Faces Class Action Amidst Safety Allegations

Updated Category News Views 160

Understanding the Class Action Against Freeport-McMoRan Recently, a prominent securities law firm announced a class action lawsuit against Freeport-McMoRan Inc. (NYSE: FCX), targeting potential securities fraud as stock prices drastically fell. This lawsuit follows serious allegations concerning the company's safety practices that may have played a part in significant...

Continue Reading
GRAIL Faces Lawsuit: Opportunity for Shareholder Action

Updated Category News Views 10

A Shaky Stage in GRAIL's Financial Play When you look at company dramas, GRAIL's latest saga is nothing short of a plot twist worthy of Wall Street headlines. The firm's recent misadventures have landed them in hot water—a securities fraud lawsuit. Investors, if you had a stake in this during the class period, it’s time to wake up and smell the potential losses....

Continue Reading
Breathe Drops: A Game-Changer for Respiratory Wellness

Updated Category News Views 294

Introducing Breathe Drops: A Revolutionary Wellness Solution In the ever-evolving world of wellness, Breathe is thrilled to unveil its latest product, Breathe Drops. This unique formula aims to enhance lung health and respiratory wellness by harnessing the power of carefully selected natural ingredients. Designed for individuals seeking natural wellness solutions, Breathe...

Continue Reading
aTyr Pharma Faces Class Action After Phase 3 Trial Setbacks

Updated Category News Views 180

Introduction to aTyr Pharma Inc. aTyr Pharma Inc. (NASDAQ: ATYR) is a biopharmaceutical company focused on developing therapies for serious diseases. The company’s innovative approach strives to improve patient outcomes through its protein therapeutics. Recent Developments In late 2025, aTyr Pharma faced a significant setback when it announced that its Phase 3 study for...

Continue Reading
Crucial Steps for EPSO-G's Upcoming Extraordinary Meeting

Updated Category News Views 65

Understanding EPSO-G's Extraordinary General Meeting EPSO-G, a key player in the energy sector, has taken an important step by convening an Extraordinary General Meeting (EGM). This decision was initiated by the Board of Energy Transmission and Exchange Group EPSO-G, representing a significant moment for the organization and its stakeholders. Purpose of the Meeting The...

Continue Reading